2016 annual financial data

Fate Therapeutics, Inc. 2016 Net margin

Fate Therapeutics, Inc. 2016 net margin with verified reported values.

Direct answer

Net margin was -760.15%.

Operating income was -31,963,000 USD and net income was -33,462,000 USD.
Operating cash flow was -29,823,000 USD.

Get free Fate Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,402,000 USD
Operating income
-31,963,000 USD
Net income
-33,462,000 USD
Operating cash flow
-29,823,000 USD